Save your place

Sign in to WhoBought

Please try again later.

Abbott Laboratories (ABT) institutional ownership

Latest close $103.10 Jul 24, 2026
Market cap$161.5B 52-week range SectorHealthcare
Funds holding · Q1 2026
2,995
reported ABT position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Net sold $6.3B
1,268 buyers · 1,727 sellers

Abbott Laboratories (ABT) price and institutional activity

Dates

Q1 2026

$14.9B bought by 1268 investors
Schwab$3.6BCapital Research Global Investors$1.2B +1,266 more
$21.2B sold by 1727 investors
J. Stern & Co. LLP-$4.4BCapital International Investors-$2.9B +1,725 more
Bought Sold Totals per quarter; hover a bar for the names.

Abbott Laboratories (ABT) institutional activity · 2,995

Investor Type Est. change Change Δ Own Date
J. Stern & Co. LLP · Reduced −$4.4B
Change −39.0M Date Q1 2026
J. Stern & Co. LLP Reduced· Q1 2026 −$4.4B −39.0M Q1 2026
Schwab · Added +$3.6B
Change +32.3M Date Q1 2026
Schwab Added· Q1 2026 +$3.6B +32.3M Q1 2026
Capital International Investors · Reduced −$2.9B
Change −25.7M Date Q1 2026
Capital International Investors Reduced· Q1 2026 −$2.9B −25.7M Q1 2026
Norges · Exited −$2.6B
Change −23.5M Δ Own −100.0% Date Q1 2026
Norges Exited· Q1 2026 −$2.6B −23.5M −100.0% Q1 2026
T. Rowe Price Investment Management, Inc. · Reduced −$1.7B
Change −15.1M Date Q1 2026
T. Rowe Price Investment Management, Inc. Reduced· Q1 2026 −$1.7B −15.1M Q1 2026
Fisher Asset Management, LLC Reduced· Q1 2026 −$1.2B −10.7M −93.4% Q1 2026
Capital Research Global Investors · Added +$1.2B
Change +10.6M Δ Own +27.1% Date Q1 2026
Capital Research Global Investors Added· Q1 2026 +$1.2B +10.6M +27.1% Q1 2026
Capital World Investors · Exited −$956M
Change −8.5M Δ Own −100.0% Date Q1 2026
Capital World Investors Exited· Q1 2026 −$956M −8.5M −100.0% Q1 2026
Morgan Stanley · Reduced −$749M
Change −6.6M Date Q1 2026
Morgan Stanley Reduced· Q1 2026 −$749M −6.6M Q1 2026
Two Sigma Investments, LP · New +$722M
Change +6.4M Date Q1 2026
Two Sigma Investments, LP New· Q1 2026 +$722M +6.4M Q1 2026
Alliancebernstein L.P. · Reduced −$526M
Change −4.7M Date Q1 2026
Alliancebernstein L.P. Reduced· Q1 2026 −$526M −4.7M Q1 2026
JPMorgan Chase & Co · Added +$517M
Change +4.6M Date Q1 2026
JPMorgan Chase & Co Added· Q1 2026 +$517M +4.6M Q1 2026
CIBC Bancorp USA Inc. · Added +$447M
Change +4.0M Date Q1 2026
CIBC Bancorp USA Inc. Added· Q1 2026 +$447M +4.0M Q1 2026
Polen Capital Management LLC · Reduced −$446M
Change −3.9M Date Q1 2026
Polen Capital Management LLC Reduced· Q1 2026 −$446M −3.9M Q1 2026
D. E. Shaw & Co., Inc. · Added +$444M
Change +3.9M Δ Own +290.2% Date Q1 2026
D. E. Shaw & Co., Inc. Added· Q1 2026 +$444M +3.9M +290.2% Q1 2026
Data through Q1 2026 · filed Jun 11, 2026
15 of 2995

Famous investor activity in Abbott Laboratories (ABT)

Abbott Laboratories (ABT) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Stratton John G. · Director Grant (A) $39K
Price $90.74 Qty 432 Owned 14K Trade date Jun 30, 2026 Filed date Jul 1, 2026
Stratton John G. Director Grant (A) $90.74 432 $39K 14K Jun 30, 2026 Jul 1, 2026
Roman Michael F. · Director Grant (A) $38K
Price $90.74 Qty 416 Owned 7K Trade date Jun 30, 2026 Filed date Jul 1, 2026
Roman Michael F. Director Grant (A) $90.74 416 $38K 7K Jun 30, 2026 Jul 1, 2026
Gonzalez Patricia Paola · Director Grant (A) $33K
Price $90.74 Qty 363 Owned 6K Trade date Jun 30, 2026 Filed date Jul 1, 2026
Gonzalez Patricia Paola Director Grant (A) $90.74 363 $33K 6K Jun 30, 2026 Jul 1, 2026
Conroy Kevin T. · Director Grant (A) $21K
Price $90.74 Qty 231 Owned 231 Trade date Jun 30, 2026 Filed date Jul 1, 2026
Conroy Kevin T. Director Grant (A) $90.74 231 $21K 231 Jun 30, 2026 Jul 1, 2026
Ahuja Nita · Director Grant (A) $31K
Price $90.74 Qty 347 Owned 450 Trade date Jun 30, 2026 Filed date Jul 1, 2026
Ahuja Nita Director Grant (A) $90.74 347 $31K 450 Jun 30, 2026 Jul 1, 2026
Morrone Louis H. · Officer Tax withholding or exercise payment (F) -$25K
Price $92.71 Qty -269 Owned 77K ΔOwn −0.4% Trade date Jun 30, 2026 Filed date Jul 1, 2026
Morrone Louis H. Officer Tax withholding or exercise payment (F) $92.71 -269 -$25K 77K −0.4% Jun 30, 2026 Jul 1, 2026
Cushman Elizabeth C. · Officer Tax withholding or exercise payment (F) -$53K
Price $94.12 Qty -560 Owned 38K ΔOwn −1.5% Trade date Jun 27, 2026 Filed date Jun 29, 2026
Cushman Elizabeth C. Officer Tax withholding or exercise payment (F) $94.12 -560 -$53K 38K −1.5% Jun 27, 2026 Jun 29, 2026
Stratton John G. · Director Buy +$174K
Price $86.82 Qty +2K Owned 23K Trade date May 7, 2026 Filed date Jun 18, 2026
Stratton John G. Director Buy $86.82 +2K +$174K 23K May 7, 2026 Jun 18, 2026
Stratton John G. · Director Grant (A) $39K
Price $102.67 Qty 382 Owned 13K Trade date Mar 31, 2026 Filed date Apr 2, 2026
Stratton John G. Director Grant (A) $102.67 382 $39K 13K Mar 31, 2026 Apr 2, 2026
Roman Michael F. · Director Grant (A) $38K
Price $102.67 Qty 367 Owned 6K Trade date Mar 31, 2026 Filed date Apr 2, 2026
Roman Michael F. Director Grant (A) $102.67 367 $38K 6K Mar 31, 2026 Apr 2, 2026
Gonzalez Patricia Paola · Director Grant (A) $33K
Price $102.67 Qty 321 Owned 6K Trade date Mar 31, 2026 Filed date Apr 2, 2026
Gonzalez Patricia Paola Director Grant (A) $102.67 321 $33K 6K Mar 31, 2026 Apr 2, 2026
Alpern Robert J. · Director Grant (A) $8K
Price $102.67 Qty 76 Owned 11K Trade date Mar 31, 2026 Filed date Apr 2, 2026
Alpern Robert J. Director Grant (A) $102.67 76 $8K 11K Mar 31, 2026 Apr 2, 2026
Ahuja Nita · Director Grant (A) $10K
Price $102.67 Qty 102 Owned 102 Trade date Mar 31, 2026 Filed date Apr 2, 2026
Ahuja Nita Director Grant (A) $102.67 102 $10K 102 Mar 31, 2026 Apr 2, 2026
Orville Jacob A. · Officer Grant (A) 13K
Owned 50K Trade date Mar 23, 2026 Filed date Mar 25, 2026
Orville Jacob A. Officer Grant (A) 13K 50K Mar 23, 2026 Mar 25, 2026
Shroff Eric · Officer Sell −$82K
Price $115.58 Qty −709 Owned 39K Trade date Mar 2, 2026 Filed date Mar 3, 2026
Shroff Eric Officer Sell $115.58 −709 −$82K 39K Mar 2, 2026 Mar 3, 2026
15 of 55
15 of 55 Sign in to continue to older insider transactions.

Abbott Laboratories (ABT) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Vanguard Group Inc 156.4M
% of shares outstanding 9.0% Filing date Feb 13, 2024
Vanguard Group Inc 156.4M 9.0% Feb 13, 2024
BlackRock Inc. 134.1M
% of shares outstanding 7.7% Filing date Jan 26, 2024
BlackRock Inc. 134.1M 7.7% Jan 26, 2024
Vanguard Capital Management LLC 130.7M
% of shares outstanding 7.5% Filing date Apr 29, 2026
Vanguard Capital Management LLC 130.7M 7.5% Apr 29, 2026
3 of 3

Abbott Laboratories (ABT) ownership FAQ

Who owns ABT?

2,995 reporting institutions disclosed ABT position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.